JAMES F POLEWACZYK Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES F POLEWACZYK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES F POLEWACZYK. JAMES F POLEWACZYK is Corporate Vice President in IDEXX LABORATORIES INC /DE ($IDXX).
Latest Insider Trading Transactions of JAMES F POLEWACZYK
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 257 | 0 | 3,184 | |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 400 | 0 | 3,441 | |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 281 | 0 | 3,841 | |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 194 | 0 | 4,122 | |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 186 | 0 | 4,316 | |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 0.00 | 900 | 0 | 4,502 | |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 91.68 | 1,090 | 99,931 | 1,090 | |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 91.68 | 8,222 | 753,793 | 8,222 | |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Payment of Exercise | F | 91.68 | 464 | 42,540 | 6,955 | 7.4 K to 7 K (-6.25 %) |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 257 | 0 | 7,419 | 7.2 K to 7.4 K (+3.59 %) |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 400 | 0 | 7,162 | 6.8 K to 7.2 K (+5.92 %) |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 281 | 0 | 6,762 | 6.5 K to 6.8 K (+4.34 %) |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 194 | 0 | 6,481 | 6.3 K to 6.5 K (+3.09 %) |
Feb 19 2013 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 186 | 0 | 6,287 | 6.1 K to 6.3 K (+3.05 %) |
Sep 05 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 34.37 | 3 | 103 | 2,910 | |
Sep 05 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 56.95 | 1,755 | 99,947 | 1,755 | |
Sep 05 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 56.95 | 1,201 | 68,397 | 1,200 | |
Sep 05 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 34.37 | 2,500 | 85,925 | 7,337 | |
Sep 05 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Sell | S | 95.01 | 5,459 | 518,661 | 6,001 | 11.5 K to 6 K (-47.64 %) |
Sep 05 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 34.37 | 3 | 103 | 11,460 | 11.5 K to 11.5 K (+0.03 %) |
Sep 05 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 56.95 | 1,755 | 99,947 | 11,457 | 9.7 K to 11.5 K (+18.09 %) |
Sep 05 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 56.95 | 1,201 | 68,397 | 9,702 | 8.5 K to 9.7 K (+14.13 %) |
Sep 05 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 34.37 | 2,500 | 85,925 | 8,501 | 6 K to 8.5 K (+41.66 %) |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 714 | 0 | 3,602 | |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 257 | 0 | 4,316 | |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 400 | 0 | 4,573 | |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 282 | 0 | 4,973 | |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 194 | 0 | 5,255 | |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Option Exercise | A | 0.00 | 929 | 0 | 5,449 | |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Option Exercise | A | 87.42 | 1,143 | 99,921 | 1,143 | |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Option Exercise | A | 87.42 | 8,105 | 708,539 | 8,105 | |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Payment of Exercise | F | 87.42 | 615 | 53,763 | 5,871 | 6.5 K to 5.9 K (-9.48 %) |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Buy | M | 0.00 | 714 | 0 | 6,486 | 5.8 K to 6.5 K (+12.37 %) |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Buy | M | 0.00 | 257 | 0 | 5,772 | 5.5 K to 5.8 K (+4.66 %) |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Buy | M | 0.00 | 400 | 0 | 5,515 | 5.1 K to 5.5 K (+7.82 %) |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Buy | M | 0.00 | 282 | 0 | 5,115 | 4.8 K to 5.1 K (+5.83 %) |
Feb 16 2012 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | CORPORATE VICE PRES ... | Buy | M | 0.00 | 194 | 0 | 4,833 | 4.6 K to 4.8 K (+4.18 %) |
Feb 22 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 56.95 | 3,603 | 205,191 | 2,401 | |
Feb 22 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 53.31 | 2,000 | 106,620 | 9,657 | |
Feb 22 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 34.37 | 8,000 | 274,960 | 9,837 | |
Feb 22 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 56.95 | 5,265 | 299,842 | 3,510 | |
Feb 22 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Sell | S | 77.66 | 5,236 | 406,640 | 4,639 | 9.9 K to 4.6 K (-53.02 %) |
Feb 22 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Sell | S | 77.58 | 12,000 | 930,917 | 9,875 | 21.9 K to 9.9 K (-54.86 %) |
Feb 22 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 56.95 | 3,603 | 205,191 | 21,875 | 18.3 K to 21.9 K (+19.72 %) |
Feb 22 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 53.31 | 2,000 | 106,620 | 18,272 | 16.3 K to 18.3 K (+12.29 %) |
Feb 22 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 34.37 | 8,000 | 274,960 | 16,272 | 8.3 K to 16.3 K (+96.71 %) |
Feb 22 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 56.95 | 5,265 | 299,842 | 8,272 | 3 K to 8.3 K (+175.09 %) |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 282 | 0 | 4,520 | |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 400 | 0 | 4,802 | |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 258 | 0 | 5,202 | |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 714 | 0 | 5,460 | |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 0.00 | 967 | 0 | 6,174 | |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 77.59 | 1,288 | 99,936 | 1,288 | |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 77.59 | 7,715 | 598,607 | 7,715 | |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Payment of Exercise | F | 77.59 | 560 | 43,450 | 3,007 | 3.6 K to 3 K (-15.70 %) |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 282 | 0 | 3,567 | 3.3 K to 3.6 K (+8.58 %) |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 400 | 0 | 3,285 | 2.9 K to 3.3 K (+13.86 %) |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 258 | 0 | 2,885 | 2.6 K to 2.9 K (+9.82 %) |
Feb 16 2011 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 714 | 0 | 2,627 | 1.9 K to 2.6 K (+37.32 %) |
Feb 17 2010 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 400 | 0 | 5,207 | |
Feb 17 2010 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 258 | 0 | 5,607 | |
Feb 17 2010 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 716 | 0 | 5,865 | |
Feb 17 2010 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 0.00 | 1,407 | 0 | 6,581 | |
Feb 17 2010 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 53.31 | 11,657 | 621,435 | 11,657 | |
Feb 17 2010 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 53.31 | 1,875 | 99,956 | 1,875 | |
Feb 17 2010 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Payment of Exercise | F | 53.31 | 516 | 27,508 | 1,913 | 2.4 K to 1.9 K (-21.24 %) |
Feb 17 2010 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 400 | 0 | 2,429 | 2 K to 2.4 K (+19.71 %) |
Feb 17 2010 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 258 | 0 | 2,029 | 1.8 K to 2 K (+14.57 %) |
Feb 17 2010 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 716 | 0 | 1,771 | 1.1 K to 1.8 K (+67.87 %) |
Page: 1